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INTRODUCTION:  Gastrosplenic  ﬁstula  (GSF)  is  a rare  condition  almost  always  associated  with  lymphoma,
with gastric  and  splenic  involvement.
CASE  REPORT:  We  report  a 52 year old  male  with gastric  lymphoma  admitted  to the  emergency
department  with  hematemesis.  The  ﬁrst chemotherapy  cycle  had  been  completed  four  weeks  before.
Oesophagoduodenoscopy  showed  a pulsatile  ulcerated  lesion.  Surgical  hemostasis  was  performed.  Four
days after  surgery,  the patient  initiated  sudden  and  massive  upper  gastrointestinal  bleeding  with  hemo-
dynamic  compromise.  A  gastrosplenic  ﬁstula  was  recognized  during  emergency  laparotomy  and  an  en
bloc total  gastrectomy  and  splenopancreatectomy  resection  was performed,  with  massive  blood  trans-
fusion.  Patient  was  discharged  13  days  after  the  second  surgery.
DISCUSSION:  Gastrosplenic  ﬁstula  is  a  rare  condition,  previously  described  associated  with  gastric  lym-pper GI surgery phoma  at  presentation  or after  treatment.  A  prompt  recognition  of  the  underlying  pathology  could  avoid
a second  surgery.
CONCLUSION:  A systematic  and  interdisciplinary  approach  is  the  key for success  in  rare  challenging  emer-
gencies.  Infrequent  etiologies  must  always  be considered  as  they  need  speciﬁc  therapeutic  approaches
that  defy  paradigms.
©  2016  The  Authors.  Published  by Elsevier  Ltd.  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
Gastrosplenic ﬁstula (GSF) is a recognized complication of gas-
ric or splenic lymphoma [1–8]. Several times described as a rare
vent, there are several cases previously reported of GSF secondary
o lymphoma in the literature, although only few cases clearly due
o primary gastric lymphoma (Pubmed: search terms gastrosplenic
stula, no restrictions, 02 October 2015). GSF may  cause the ﬁrst
ign of the underlying disease or may  occur after chemotherapy.
t can be incidentally diagnosed and/or may  present as a massive
pper GI bleeding needing life-saving emergency surgery [1–8].
With this case report, our aim is to highlight the impor-
ance of subtle clinical aspects that could lead to the diagnosis
f life-threatening conditions in patients with routine clinical
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2. Presentation of case
52 year old male, admitted to the emergency department
(ED) with dizziness and upper gastrointestinal bleeding. He
had a recent diagnosis of gastric B cell lymphoma, having
complete chemotherapy (Cyclophosphamide, Hydroxidaunoru-
bicin, Oncovin and Prednisolone—CHOP) four weeks prior to ED
admission. The patient was  hemodinamically stable. Oesopha-
gogastroduodenoscopy showed a pulsatile whitish ulcerated lesion
between body and gastric fundus in the grater curvature—Fig. 1.
Given endoscopic therapy was unsuccessful, with patient hemody-
namic compromise under blood transfusion – 2 red cell pack (RCP)
and ﬂuid resuscitation – an emergency laparotomy was performed.
Gastrotomy with ulcer bed biopsy and hemostasis restored hemo-
dynamic stability. The immediate post-operative was uneventful
and multiorgan function was restored with intensive medicine sup-
port.
At the fourth day after surgery, the patient presented with
sudden onset of hematemesis and melena, with confusion and
hemodynamic deterioration. Fluid resuscitation and blood trans-
fusion was  immediately started and emergency surgery was
performed. Re-laparotomy showed gastric distension ﬁlled with
blood. After gastrotomy, an active bleeding 1 cm ulcer at the fundus,
with ﬁstulization to the splenic vein, was found. An en bloc Roux-
Y total gastrectomy with splenectomy and distal pancreatectomy
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Oesophagogastroduodenoscopy at admission, showing a clot (a) covering a
ulsatile whitish ulcerated lesion (b).
as performed – Fig. 2 – and the patient was transferred to the
ntensive Care Unit (ICU) for intensive organ support and massive
lood transfusion—24 RCP, 7 cryoprecipitate, 3 fresh frozen plasma
nd 1 platelet pool.
Patient was discharged after three days in the ICU and ten days
n the surgical ward. Before discharge, an arteriography was per-
ormed for splenic artery embolization − Fig. 3(a) and (b). The
eason for this procedure was that, if there was splenic artery
nvolvement by lymphoma, new chemotherapy cycles could lead
o tumor necrosis and splenic artery hemorrhage. This was  decided
n a multidisciplinary meeting.
ig. 2. Specimen of en bloc total gastrectomy with splenopancreatectomy resection.Fig. 3. (a) celiac axis arteriography (b) splenic artery embolization.
Surgical pathology analysis showed a 6 cm gastric fundus
ulcer, with perigastric adipose tissue attached to the splenic
capsule, with ﬁbrinopurulent tissue. Histological and immunohis-
tochemical analysis showed a high grade non-Hodgkin transmural
lymphoma, transmural inﬂammatory inﬁltrate with gastric wall
ﬁssures, and 10 lymph nodes with no neoplasia − Fig. 4(a) and (b).
Three months after surgery patient was lost to follow up since
he started treatment in another hospital.
3. Discussion
According to European Society for Medical Oncology (ESMO) [9]
and National Comprehensive Cancer Network (NCCN) [10] guide-
lines, gastric lymphoma therapy involves H. pylori eradication and
radiotherapy if the disease persists. If symptomatic advanced dis-
ease, than chemotherapy is recommended (usually RCHOP—CHOP
plus Rituximab – or RCVP – Rituximab, Cyclophosphamide, Vin-
cristine and Prednisolone). Surgery is the option when there is
tumour or treatment associated complications, such as perforation
or haemorrhage.
This case report shows demographic, clinical and histopatho-
logical ﬁndings similar to those described in the literature [1–8]:
a 50 year old male with B cell gastric lymphoma. However, mas-
sive upper GI bleeding is usually a disease ﬁrst presentation or
treatment associated complication during chemotherapy (and not
4 weeks after chemotherapy).
Surgical decision was  in accordance with literature [1–4,6,8].
However, it seemed to be the opposite of damage control surgery,
where minimal procedures should be preferred to stop haemor-
rhage and peritoneal contamination with immediate intensive care
support. In this case, as in others reported [1–4,6,8], major surgery
with en bloc gastric, splenic and distal pancreatic resection was
necessary to stop haemorrhage and peritoneal contamination.
Splenic artery embolization was performed to avoid the risk of
re-bleeding during future chemotherapy cycles, considering that
the remaining splenic vessels could be involved by the lymphoma. It
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Fig. 4. (a) Gastric wall extensively ulcerated with transmural inﬂammatory inﬁltrate. (b) Large atypical lymphoid cells interspersed among inﬂammatory cells, consistent
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cith  residual high-grade non-Hodgkin lymphoma.
as a multidisciplinary meeting decision, although not previously
eported.
Although peptic ulcer disease may  lead to major gastric haem-
rrhage, the proximal gastric corpus is not the usual topography
or this pathology. The surgical report also describes a communica-
ion between splenic vein and the ulcer. We  consider that it is more
easonable to explain the whole physiopathology and clinical pro-
ess as a major bleeding secondary to a gastro-splenic vein ﬁstula,
han an atypical peptic ulcer with haemorrhage involving splenic
essels in a patient with gastric lymphoma.
Although not clearly reported previously in the literature, the
ime sequence of the events suggests that tumour lysis after
hemotherapy may  be the leading event for haemorrhage.
Critical retrospective analysis of the ﬁrst procedure suggests
hat an initially aggressive surgical approach would have been
ore efﬁcient and useful for the permanent treatment of this
atient. However, a standard approach with haemostatic ulcer
uture and biopsy seemed at the time to be adequate and a delayed
eﬁnitive surgical treatment could be performed as an elective
rocedure. Knowing the patient’s recent past medical history of
hemotherapy for gastric lymphoma, a high probability of haemor-
hage recurrence led to a large period of haemodynamic continuous
onitoring for prompt emergency therapy.
. Conclusion
A systematic approach, a critical attitude, and an efﬁcient inter-
isciplinary cooperation, are the key for success in rare difﬁcult
linical situations.onﬂict of interest
None. [
pen Access
his article is published Open Access at sciencedirect.com. It is distrib
ermits unrestricted non commercial use, distribution, and reproduct
redited.Ethical approval
Written Informed Consent was given, according to the HFF
EPE—Mod.016/T.DC/V6/2014 approved by the Institutional Review
Board.
Funding
None.
References
[1] J. Favre Rizzo, E. López-Tomassetti Fernández, J. Ceballos Esparragón, L.
Santana Cabrera, J.R. Hernández Hernández, Massive upper gastrointestinal
bleeding secondary to gastrosplenic ﬁstula, Rev. Esp. Enferm. Dig. 105 (9)
(2013 Oct) 570–871.
[2] A. García Marín, L. Bernardos García, A. Vaquero Rodríguez, L. Menchén Viso,
F.  Turégano Fuentes, Spontaneous gastrosplenic ﬁstula secondary to primary
gastric lymphoma, Rev. Esp. Enferm. Dig. 101 (1) (2009 Jan) 76–78.
[3] M.  Kerem, O. Sakrak, T.U. Yilmaz, F.A. Gultekin, A. Dursun, A. Bedirli,
Spontaneous gastrosplenic ﬁstula in primary gastric lymphoma: surgical
management, Asian J. Surg. 29 (4) (2006 Oct) 287–290.
[4] K.A. Carolin, S.H. Prakash, Y.J. Silva, Gastrosplenic ﬁstulas: a case report and
review of the literature, Am.  Surg. 63 (11) (1997 Nov) 1007–1010.
[5] K.M. Hiltunen, I. Airo, J. Mattila, O. Helve, Massively bleeding gastrosplenic
ﬁstula following cytostatic chemotherapy of a malignant lymphoma, J. Clin.
Gastroenterol. 13 (4) (1991 Aug) 478–481.
[6] L.D. Rothermel, C.L. Chadwick, T. Thambi-Pillai, Gastrosplenic ﬁstula:
etiologies, diagnostic studies, and surgical management, Int. Surg. 95
(July–September (3)) (2010) 270–272.
[7] K.M. Moghazy, Gastrosplenic ﬁstula following chemotherapy for lymphoma,
Gulf J. Oncol. (January (3)) (2008) 64–67.
[8] K.M. Hiltunen, I. Airo, J. Mattila, O. Helve, Massively bleeding gastrosplenic
ﬁstula following cytostatic chemotherapy of a malignant lymphoma, J. Clin.
Gastroenterol. 13 (4) (1991 Aug) 478–481.
[9] E. Zucca, M.  Dreyling, on behalf of the ESMO Guidelines Working Group,
Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice
Guidelines for diagnosis, treatment and follow-up, Ann. Oncol. 21 (Suppl. 5)
(2010) v175–v176.
10] NCCN Clinical Practice Guidelines in Oncology. Non-Hodgkin´s Lymphoma,
Marginal Zone Lymphomas. V.2.2015.uted under the IJSCR Supplemental terms and conditions, which
ion in any medium, provided the original authors and source are
